Physician profile
Adil Memon
NPI 1932605987
$1,004.67
in general payments reported to CMS, 2019-2025
8 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $146 · 2023: $178 · 2024: $70.13 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782 · Education: $76.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.90 |
| Education | $76.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $247.83 | 2022-2023 | Ocaliva |
| Janssen Biotech, INC. | $219.32 | 2025 | Tremfya |
| Erbe USA INC | $150.00 | 2025 | Erbevio3apc3 |
| Mallinckrodt Hospital Products INC. | $148.66 | 2025 | Terlivaz |
| Abbvie INC. | $93.06 | 2025 | |
| Abbott Laboratories | $70.13 | 2024 | Infinity |
| Exact Sciences Corporation | $49.74 | 2023 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $25.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Memon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.